Form 4: enGene Holdings CEO Ronald Cooper Buys 10,000 Shares
SEC Form 4 Filing
enGene Holdings CEO Ronald Cooper recently purchased 10,000 shares of the company's common stock at an average price of $5.70.
Summary
- On September 27, 2024, Ronald Harold Wilfred Cooper, the CEO of enGene Holdings Inc., purchased 10,000 shares of the company's common stock.
- The purchase was made at a weighted average price of $5.70 per share, with individual transactions ranging from $5.50 to $5.97.
- Following the transaction, Cooper directly owns 10,000 common shares of enGene Holdings Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares could indicate confidence in the company, but it's a relatively small transaction.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal about the company's prospects.
Industry Context
This is a standard SEC Form 4 filing, which is common when company insiders, like the CEO, trade their company's stock. It provides transparency to the market.
Stakeholder Impact
- The CEO's share purchase could have a minor positive impact on shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 09/27/2024 | Date of the transaction: Ronald Cooper purchased 10,000 shares of enGene Holdings Inc. |
| 10/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.